Revolution Medicines News

Most Shareholders Will Probably Agree With Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation

Key Insights Revolution Medicines will host its Annual General Meeting on 20th of June Total pay for CEO Mark Goldsmith includes US$631.1k salary The total compensation is similar to the average f

Simply Wall StJun 15 09:26 ET

Form 144 | Revolution Medicines(RVMD.US) Officer Proposes to Sell 218.4K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 14, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Officer Wei Lin intends to sell 5,414 shares of its common stock on Jun 17, with

moomoo NewsJun 14 17:40 ET

Form 144 | Revolution Medicines(RVMD.US) Officer Proposes to Sell 130.74K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 14, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Officer Kelsey Stephen Michael intends to sell 3,241 shares of its common stock

moomoo NewsJun 14 17:25 ET

Form 144 | Revolution Medicines(RVMD.US) Officer Proposes to Sell 172.29K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 14, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Officer Horn Margaret A intends to sell 4,271 shares of its common stock on Jun

moomoo NewsJun 14 17:11 ET

Form 144 | Revolution Medicines(RVMD.US) Officer Proposes to Sell 466.37K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 14, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Officer GOLDSMITH MARK A intends to sell 11,561 shares of its common stock on Ju

moomoo NewsJun 14 17:00 ET

Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable

Yahoo FinanceJun 14 07:54 ET

Revolution Medicines(RVMD.US) Officer Sells US$299.94K in Common Stock

$Revolution Medicines(RVMD.US)$ Officer GOLDSMITH MARK A sold 7,500 shares of common stock on Jun 3, 2024 at an average price of $39.9923 for a total value of $299.94K.Source: Announcement What is sta

moomoo NewsJun 5 17:01 ET

Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing

Mark A Goldsmith, Director, President and Chief Executive Officer, on June 03, 2024, sold 7,500 shares in Revolution Medicines (RVMD) for $299,942. Following the Form 4 filing with the SEC, Goldsmith

MT NewswiresJun 5 16:21 ET

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Revolution Medicines, Inc. (Nasdaq: RVMD) today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference.

GlobeNewswireJun 5 16:05 ET

Form 144 | Revolution Medicines(RVMD.US) Director Proposes to Sell 287.48K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 3, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Director MARK A GOLDSMITH TODSUBJECT TO STA RULES intends to sell 7,500 shares of

moomoo NewsJun 3 16:42 ET

Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo

Seeking AlphaMay 25 10:24 ET

Revolution Medicines(RVMD.US) Officer Sells US$58,670.87 in Common Stock

$Revolution Medicines(RVMD.US)$ Officer Cislini Jeff sold 1,500 shares of common stock on May 21, 2024 at an average price of $39.1139 for a total value of $58,670.87.Source: Announcement What is stat

moomoo NewsMay 22 16:54 ET

Oppenheimer Remains a Buy on Revolution Medicines (RVMD)

TipRanksMay 14 07:56 ET

Express News | HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $44 Price Target

BenzingaMay 13 06:33 ET

Buy Rating on Revolution Medicines With a $44 Target Amid Strong Financials and Upcoming Clinical Catalysts

TipRanksMay 13 06:27 ET

Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...

Yahoo FinanceMay 10 12:37 ET

Health Check: How Prudently Does Revolution Medicines (NASDAQ:RVMD) Use Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n

Simply Wall StMay 10 10:27 ET

Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Keros Therapeutics (KROS)

TipRanksMay 10 01:20 ET

Earnings Call Summary | Revolution Medicines(RVMD.US) Q1 2024 Earnings Conference

The following is a summary of the Revolution Medicines, Inc. (RVMD) Q1 2024 Earnings Call Transcript:Financial Performance:Revolution Medicines reported a net loss of $116.0 million or $0.70 per share

moomoo AIMay 9 12:05 ET · Conference Call

Revolution Medicines Is Maintained at Outperform by Wedbush

Revolution Medicines Is Maintained at Outperform by Wedbush

Dow JonesMay 9 08:57 ET